D2-specific discriminative stimuli: parameters, blocking, and rebound.
This study characterizes the cue properties of quinpirole (LY 171555), a selective D2 agonist, and the blocking capabilities of spiperone, a selective D2 antagonist. After rats were trained to discriminate 0.025 mg/kg quinpirole from distilled water, a dose-response curve and time course of the quinpirole discriminative stimulus were determined. The effectiveness of three doses of spiperone in blocking the discriminative stimulus produced by 0.02 mg/kg quinpirole was then assessed. Finally, the time course of spiperone's blocking action was determined. Given the putative selective action of these drugs on D2 receptors and the parametric data presented here, it was predicted that following chronic treatment with spiperone, a rebound increase in quinpirole-appropriate responding would occur. Neither chronic treatment with spiperone nor chronic treatment with haloperidol produced the predicted changes. This result, however, may be confined to the specific dose and time parameters used.
Huffman
E M
EM
Department of Psychology, Vanderbilt University, Nashville, TN 37240, USA.
Caul
W F
WF
Strand
E J
EJ
Jones
J R
JR
Barrett
R J
RJ
D000818:Animals; D003463:Cues; D004192:Discrimination, Psychological / Q000187:drug effects*; D018491:Dopamine Agonists / Q000494:pharmacology; D065127:Dopamine D2 Receptor Antagonists; D004305:Dose-Response Relationship, Drug; D004873:Ergolines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005508:Food Deprivation / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D019257:Quinpirole; D051381:Rats; D017207:Rats, Sprague-Dawley; D012055:Reinforcement Schedule; D013134:Spiperone / Q000494:pharmacology
D018491:Dopamine Agonists; D065127:Dopamine D2 Receptor Antagonists; D004873:Ergolines; D019257:Quinpirole; D013134:Spiperone; D006220:Haloperidol